Page last updated: 2024-09-05

sb 203580 and guanosine 5'-o-(3-thiotriphosphate)

sb 203580 has been researched along with guanosine 5'-o-(3-thiotriphosphate) in 1 studies

Compound Research Comparison

Studies
(sb 203580)
Trials
(sb 203580)
Recent Studies (post-2010)
(sb 203580)
Studies
(guanosine 5'-o-(3-thiotriphosphate))
Trials
(guanosine 5'-o-(3-thiotriphosphate))
Recent Studies (post-2010) (guanosine 5'-o-(3-thiotriphosphate))
3,48941,1375,5428368

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gomes, P; Hopfer, U; Jose, PA; Pedrosa, R; Soares-da-Silva, P1

Other Studies

1 other study(ies) available for sb 203580 and guanosine 5'-o-(3-thiotriphosphate)

ArticleYear
Gialpha3 protein-coupled dopamine D3 receptor-mediated inhibition of renal NHE3 activity in SHR proximal tubular cells is a PLC-PKC-mediated event.
    American journal of physiology. Renal physiology, 2004, Volume: 287, Issue:5

    Topics: Animals; Calcium; Cell Line; Cholera Toxin; Dopamine Antagonists; Down-Regulation; Flavonoids; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Imidazoles; Kidney Tubules, Proximal; Pertussis Toxin; Protein Kinase C; Pyridines; Rats; Rats, Inbred SHR; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, G-Protein-Coupled; Sodium-Hydrogen Exchanger 3; Sodium-Hydrogen Exchangers; Sulpiride; Tetrahydronaphthalenes; Type C Phospholipases

2004